Authorization of genetically modified maize DP202216 on the European market

The European Parliament has examined the Commission's decision to authorize the marketing of genetically modified maize DP202216. This adopted text analyzes the authorization process and concerns about environmental and health impacts. The decision affects European producers, consumers, and the environment.

Context and objectives

Based on Regulation (EC) No 1829/2003 on genetically modified food and feed, the procedure was initiated by Pioneer company in 2019. The European Food Safety Authority (EFSA) issued a favorable opinion in February 2024. The objective is to assess the risks and benefits of this genetically modified organism before authorization.

Key measures

• Analysis of EFSA's opinion certifying the safety of maize DP202216 for consumption
• Examination of Member States' objections regarding the monitoring plan and environmental risks
• Assessment of potential impact of herbicide resistance on biodiversity
• Verification of compliance with sustainable development goals and biodiversity framework
• Analysis of the decision-making process and European Parliament's objections

Timeline and implementation

The authorization decision was adopted in 2024 following consultations in specialized committees. The European Commission is responsible for implementation with continuous monitoring by Member States. EFSA will oversee food safety aspects, and national authorities will control market application.

Impact for citizens and stakeholders

Farmers may benefit from higher yields but face risks of herbicide dependency. Consumers will find products derived from this maize on the market with EFSA's safety guarantee. The environment may be affected by increased herbicide use and potential impact on biodiversity. Continuous monitoring of long-term effects is important.